Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RENCA macrobeads in metastatic pancreatic or colorectal cancer
NCT01053013Phase 2Completed
- Sponsor
- Rogosin Institute
- Start
- Apr 2010
- Primary completion
- Apr 2016
- Modality
- Cell Therapies, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of RENCA macrobeads in pancreatic adenocarcinoma (PDAC), colorectal cancer (CRC), sponsored by Rogosin Institute. Started Apr 2010; status: completed.
02
Drugs
RENCA macrobeads
03
Conditions
pancreatic adenocarcinoma (PDAC)colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01053013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01053013.